Onco-Innovations Cash Flow Statement

Financials in millions CAD. Fiscal year is May - April.

Millions CAD. Fiscal year is May - Apr.

Fiscal Year	FY 2024	FY 2023
Period Ending	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023
Net Income	-0.06	-0
Change in Accounts Payable	0.06	0
Change in Other Net Operating Assets	-0.01	-
Operating Cash Flow	-0.01	-0
Issuance of Common Stock	0.08	0.02
Financing Cash Flow	0.08	0.02
Net Cash Flow	0.07	0.02

Source: S&P Global Market Intelligence. Standard template. Financial Sources.